Lobbying Information
Subject Matters
- Budget
- Consumer Issues
- Education
- Government Procurement
- Health
- Industry
- Intellectual Property
- Internal Trade
- International Relations
- International Trade
- Research and Development
- Science and Technology
- Taxation and Finance
Subject matters added through a monthly communication report
Subject Matter Details
Policies or Program
- Federal/Provincial/Territorial vaccine procurement programs administered by Science and Professional Services Procurement Directorate (SPSPD) of PWGSC with regard to the recommendation and funding of vaccines through Public Health programs by governments in Canada, including issues that relate to the National Immunization Strategy.
- Sanofi BioGENEius Challenge Canada program in support of the promotion of biotechnology and science education and innovation in Canada
Communication Techniques
-
Written communication
-
Oral communication
Government Institutions
-
Canadian Institutes of Health Research (CIHR)
-
Employment and Social Development Canada (ESDC)
-
Federal Economic Development Agency for Southern Ontario (FedDev)
-
Finance Canada (FIN)
-
Foreign Affairs, Trade and Development Canada
-
Health Canada (HC)
-
House of Commons
-
Industry Canada
-
National Research Council (NRC)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Public Health Agency of Canada (PHAC)
-
Public Works and Government Services Canada
-
Senate of Canada
In-house Corporation Details
Description of activities
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and development.
Responsible officer name and position during the period of this registration
J .Mark Lievonen,
President
Government funding
End date of the last completed financial year:
2013-12-31
List of Government Funding
|
Government Institution
|
Funding Received in Last Financial Year
|
Funding Expected in Current Financial Year
|
|
Ontario Ministry of Research and Innovation
|
$613,347.00
|
Yes
|
In-house Corporation Contact Information
Address:
1755 Steeles Avenue West
Toronto, ON M2R 3T4
Canada
Telephone number:
416-667-2760
Fax number:
416-667-2977
Parent Company Information
- Sanofi
-
174 avenue de France
Paris 75013
France
Subsidiary Beneficiary Information
- Sanofi Pasteur Inc.
-
1 Discovery Drive
Swiftwater, PA 18370
United States of America
Lobbyists Details
Senior Officers whose lobbying activities represent less than 20% of their Duties
- J. Mark Lievonen,
President |
No public offices held
- Dion Neame,
Senior Director, Scientific and Medical Affairs |
No public offices held
- Truong Ta,
Director, Marketing and Strategic Business Planning |
No public offices held
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
- Robert Van Exan,
Director, Immunization Policy |
No public offices held
